Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: HER2-positive Advanced Breast Cancer
Interventions: DRUG: Inetetamab Combined With Pyrotinib and Vinorelbine
Sponsor: Zhejiang Cancer Hospital